Assistant Professor (Scientist-D)
Ours is a neuronanotherapeutics group where we try to develop different nanostructures for treating CNS associated disorders like glioblastoma, Alzheimer's etc. Our groups other interests involve design and synthesis novel biocompatible and multifunctional nanostructures, mostly peptide based self-assembled nanostructures for achieving effective drug delivery across the blood brain barrier. We also work towards the development of theranostic nanosystems for effective imaging and therapy of dreaded diseases like cancer, neurodegenerative disorders, cataract etc. Besides, our group also work towards the development of various nanosensing platforms based on SERS, electrochemical or fluorescence based techniques for aiding detection and diagnosis of glioblastoma, neurodegenerative disorders etc.
Reg. No.: PH15213
Reg. No.: Ph16241
Reg. No.: PH17206
empty! record not found
Effect of Particle Size and Viscosity of Suspensions on Topical Ocular Bioavailability of Budesonide, a Corticosteroid: Vooturi S, Bourne D, Panda JJ, Choi S , Kim H, Yandrapu SK, Kompella UB, (2020) Journal of Ocular Pharmacology and Therapeutics, Journal of Ocular Pharmacology and Therapeutics: .
Comprehensive evaluation of chitosan nanoparticle based phage lysin delivery system; a novel approach to counter S. pneumoniae infections: Gondil VS, Dube T, Panda JJ, Yennamalli RM, Harjai K, Chhibber S, (2020) Int J Pharm., 573: 118850.
Redox-Responsive Dipeptide Nanostructures toward Targeted Cancer Therapy: Chibh S, Kour A, Yadav N, Kumar P, Yadav P, Chauhan VS, Panda JJ, (2020) ACS Omega, 5: 3365-3375.
Cholesterol bound Plasmodium falciparum co-chaperone 'PFA0660w' complexes with major virulence factor 'PfEMP1' via chaperone 'PfHsp70-x'.Behl A: .Behl A, Kumar V, Bisht A, Panda JJ, Hora R, Mishra PC., (2019) Sci Rep, 9(1): 2664.
Short peptide-based smart targeted cancer nanotherapeutics: a glimmer of hope.: Mishra J, (2019) Ther Deliv, 10(3): 135-138. DOI: 10.4155/tde-2019-0005
Nanotheranostics, a future remedy of neurological disorders.: Sharma M, Dube T, Chibh S, Kour A, Mishra J, (2019) Expert Opin Drug Deliv., 16(2): 113-128. DOI: 10.1080/17425247.2019.1562443
Gold Nano-/Micro-Roses on Levodopa Microtubes for SERS-Based Sensing of Gliomas: Taru Dube, Nitin Kumar, Avneet Kour, Jibanananda Mishra, Manish Singh,Bhanu Prakash,Jiban J Panda, (2019) ACS Appl. Nano Mater, 2,5: 2663. DOI: 10.1021/acsanm.9b00155
Carrier-free self-built aspirin nanorods as anti-aggregation agents towards alpha-crystallin-derived peptide aggregates: potential implications in non-invasive cataract therapy: Anjali Bisht, Manju Sharma, Shikha Sharma, Md. Ehesan Ali,Jiban J. Panda, (2019) Journal of Materials Chemistry B, 7: 6945-6954. DOI: 10.1039/C9TB01435G
Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice.: Varshney A, Singh AK, Yadav N, Bihari C, Biswas S, Sarin SK, Chauhan VS., (2018) Hepatology, 67(4): 1392-1407. DOI: 10.1002/hep.29643
PHISTc protein family members localize to different subcellular organelles and bind Plasmodium falciparum major virulence factor PfEMP-1: Kumar V, Kaur J, Singh AP, Singh V, Bisht A, Mishra PC, Hora R. FEBS J., (2018) 285(2): 294-312. DOI: 10.1111/febs.14340
Arginine-α, β-dehydrophenylalanine Dipeptide Nanoparticles for pH-Responsive Drug Delivery.: Singh PK, Chibh S, Dube T, Chauhan VS, (2018) Pharm Res., 35(2): 35. DOI: 10.1007/s11095-017-2299-8
Plasmodium falciparum protein 'PfJ23' hosts distinct binding sites for major virulence factor 'PfEMP1' and Maurer's cleft marker 'PfSBP1': .Kaur J, Kumar V, Singh AP, Singh V, Bisht A, Dube T, Behl A, Mishra PC, Hora R., (2018) Pathog Dis., 76(9): . DOI: 10.1093/femspd/fty090
Efficacy of Dipeptide-Coated Magnetic Nanoparticles in Lung Cancer Models Under Pulsed Electromagnetic Field.: Baskar G, Ravi M, Khatri A, Dev B, Santosham R, Sathiya S, Babu CS, Chauhan VS, Rayala SK, Venkatraman G., (2017) Cancer Invest., 35(6): 431-442. DOI: 10.1080/07357907.2017.1318894
Nanoparticles generated from a tryptophan derivative: physical characterization and anti-cancer drug delivery: Dube T, Mandal S, (2017) Amino Acids, 49(5): 975-993. DOI: 10.1007/s00726-017-2403-8.
Receptor Targeted Polymeric Nanostructures Capable of Navigating across the Blood-Brain Barrier for Effective Delivery of Neural Therapeutics.: Dube T, Chibh S, Mishra J, (2017) ACS Chem Neurosci., 8(10): 2105-2117. DOI: 10.1021/acschemneuro.7b00207
Trends in cancer nanomedicine: A.K. Ganguli,A. Shanavas, S. Roy, D. Sharma,S. Karmakar, (2016) Nano Digest, .
Short peptide based nanotubes capable of effective curcumin delivery for treating drug resistant malaria.: Mukherjee TK, Chauhan VS,Alam S, (2016) Nanobiotechnology, 14: 26. DOI: 10.1186/s12951-016-0179-8
Self-assembled dipeptide-based nanostructures: tiny tots with great applications: Mishra J, (2016) Ther Deliv., 7(2): 59-62. DOI: 10.4155/tde.15.85
Short peptide based self-assembled nanostructures: implications in drug delivery and tissue engineering.: Chauhan VS, (2014) Polym. Chem., 5: 4418-4436. DOI: 10.1039/C4PY00173G
Antimicrobial activity of cationic peptides in endodontic procedures: Winfred SB, Meiyazagan G,Nagendrababu V, Deivanayagam K, Chauhan VS, (2014) Eur J Dent, 8(2): 254-60. DOI: 10.4103/1305-7456.130626
Self-assembled nanoparticles based on modified cationic dipeptides and DNA: novel systems for gene delivery.: Varsheney A, Chauhan VS, (2013) Nanobiotechnology, 11(1): 18. DOI: 10.1186/1477-3155-11-18.
Modified dipeptide nanoparticles: vehicles for tumor targeted delivery.: Kaul A, Kumar S, Alam S, Mishra AK, Kundu, GC, Chauhan, VS, (2013) Nanomedicine, 8(12): 1927-1942. DOI: 10.2217/nnm.12.201
Dipeptide Nanogels for Anticancer Drug Delivery. In: Proceedings of 82nd Annual symposium of the National academy of sciences India (NASI) on “Nanoscience and Technology for Mankind”: Chauhan VS, (2013) .
Novel dipeptide nanoparticles for effective curcumin delivery.: Alam S, Chauhan VS, (2012) International Journal of Nanomedicine, 7: 4207–4222. DOI: 10.2147/IJN.S33015
Novel dipeptide nanoparticles for effective hydrophobic drug Delivery. Nanoparticle Assembly: VS Chauhan,S Alam, (2011) Fundamentals to Applications, .
Designed peptides as model self-assembling nanosystems: characterization and potential biomedical applications.: Kaul A, Alam S, Babbar AK, Mishra AK, Chauhan VS., (2011) Therapeutic delivery, 2(10): 2839-48. DOI: 10.4155/tde.10.93
Nanoworld of peptide self-assembly. In: souvenir of silver jubilee celebration of Jupiter Biosciences: Chauhan VS, (2010) 37-43.
3D cell growth and proliferation on a RGD functionalized nanofibrillar hydrogel based on a conformationally restricted residue containing dipeptide.: Dua R, Mishra A, Mittra B, Chauhan VS., (2010) Acs Applied Materials and Interfaces, . DOI: 10.1021/am1005173
Design, Synthesis and Potential Applications of Conformationally Restricted Peptides: VS Chauhan, (2010) Journal of Peptide Science, 16: 199-199.
Stimuli responsive self-assembled hydrogel of a low molecular weight free dipeptide with potential for tunable drug delivery.: Mishra A, Basu A, Chauhan VS, (2008) Biomacromolecules, 9(8): 2244–2250.
Nanovesicles based on self-assembly of conformationally constrained aromatic residue containing amphiphilicdipeptides: Mishra A, Basu A, Chauhan VS., (2008) Langmuir, 24(9): 4571-4576. DOI: 10.1021/la7034533
Selection of salt tolerant plants of Nicotianatabacum L. through in vitro and its biochemical characterization.: Rout GR, Senapati SK, (2008) ActaBiol Hung, 59(1): 77-92.
Nanomed: Nanotechnol: SK Sahoo, S Parveen, (2007) Biol. Med, 3 (1): 20-31.
The present and future of nanotechnology in human health care. Journal of Nanomedicine: Nanotechnology, Biology and Medicine.: Sahoo SK, Parveen S, (2007) 3(1): 20-31.
Nanoworld of peptide self-assembly. In: souvenir of silver jubilee celebration of Jupiter Biosciences Chauhan VS, (2010) 37-43.
Modified dipeptide nanoparticles: vehicles for tumor targeted drug and gene delivery: Panda JJ, (2012) .
Design of low molecular weight dipeptides containing conformationally constraining residue DPhe into stimuli responsive self-assembling hydrogels with potential drug delivery applications: 1735/DEL/2008, (2008) .
Enhanced and effective delivery of microrna by using ligand modified self-assembled cationic dipeptide nanoparticles in hepatocellular carcinoma (HCC),: A Varshney, JJ Panda, AK Singh, SB Rooge, S Biswas, SK Sarin, (2019) Journal of Hepatology, S411: .
Nanoparticles generated from a tryptophan derivative: physical characterization and anticancer drug delivery: Taru Dube, (2017) Crick Nano Science Day,CSIO, Chandigarh., .
Development of Biocompatible Peptide Based Nanostructures Capable Of Traversing the Blood Brain Barrier for Targeting Glioblastoma/Brain Tumors: Crick Nano Science Day,INST, (2016) .
Multimodal Glioblastoma Therapy by Blood Brain Barrier Traversing and Glioma Targeting Anti-cancer Peptide Theranostic Nanoparticles.: at National Institute of Plant Genome Research, New Delhi., (2019) BioCARe Conclave, .
Small Peptide Nanotherapeutics: For Effective Drug Delivery towards various disorders, Multi Omics approaches to Diseases” in the CME Dept. of Experimental Medicine & Biotechnology, PGIMER, Chandigarh., (2019) .
Participated and had oral presentation in ASIA-ARVO: New Delhi, India, (2013) .
Biotechnology (Nanotechnology); International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
BiotechnologyUtkal University, Orissa, India (1 st Division).
Chemistry, Zoology, Botany, [Honours]Utkal University, Orissa, India. (1 st Division)
Scientist D:Institute of Nano Science and Technology, Phase 10, Sector 64,, Mohali Punjab, India (March 2014 to Present till date )
Visiting Research Scholar:Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver,, USA (April 2013 to March 2014 )
UNESCO-L?Oreal International Fellow:Skagg’s School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver,, USA (December 2011 to December 2013 )
Research Associate:Malaria Research Lab., International Center for Genetic Engineering and Biotechnology (ICGEB), ArunaAsaf Ali Marg, JNU Complex,, New Delhi (December 2010 to December 2011 )
Senior Research Fellow:Malaria Research Lab., ICGEB, ArunaAsaf Ali Marg, JNU Complex, New Delhi (August 2008 to July 2010 )
Junior Research Fellow:Malaria Research Lab., ICGEB, ArunaAsaf Ali Marg, JNU Complex,, New Delhi (August 2006 to July 2008 )
Junior Research Fellow:Laboratory for Nanomedicine, Institute of Life Science, Bhubaneswar,, Orissa, India (December 2005 to May 2006 )
International Fellowship for Biomedical Scientists-2019
© Copyright Institute of Nano Science and Technology 2014 - 2020 All Rights Reserved With Institute of Nano Science and Technology